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The peptidoglycan sensor Nod2 and the autophagy
protein ATG16L1 have been linked to Crohn’s dis-
ease (CD). Although Nod2 and the related sensor,
Nod1, direct ATG16L1 to initiate anti-bacterial auto-
phagy, whether ATG16L1 affects Nod-driven inflam-
mation has not been examined. Here, we uncover
an unanticipated autophagy-independent role for
ATG16L1 in negatively regulating Nod-driven inflam-
matory responses. Knockdown of ATG16L1 expres-
sion, but not that of ATG5 or ATG9a, specifically
enhanced Nod-driven cytokine production. In addi-
tion, autophagy-incompetent truncated forms of
ATG16L1 regulated Nod-driven cytokine responses.
Mechanistically, we demonstrated that ATG16L1
interfered with poly-ubiquitination of the Rip2
adaptor and recruitment of Rip2 into large signaling
complexes. The CD-associated allele of ATG16L1
was impaired in its ability to regulate Nod-driven
inflammatory responses. Overall, these results
suggest that ATG16L1 is critical for Nod-dependent
regulation of cytokine responses and that disruption
of this Nod1- or Nod2-ATG16L1 signaling axis could
contribute to the chronic inflammation associated
with CD.
INTRODUCTION
Crohn’s disease (CD) is characterized by dyseregulatedmucosal
immune responses in the intestine; these responses lead to
aberrant inflammation that is most likely directed toward innoc-
uous components of the microbiota. Several genes involved in
the innate immune response to pathogens, including NOD2
and ATG16L1, have been identified as susceptibility loci for the
development of CD (Hampe et al., 2007; Hugot et al., 2001;
Ogura et al., 2001a). However, how these genes function individ-858 Immunity 39, 858–873, November 14, 2013 ª2013 Elsevier Inc.ually as well as in concert to promote balanced inflammatory
responses at the level of the gut mucosa remains unresolved.
Nod1 and Nod2 are members of the Nod-like receptor (NLR)
family of intracellular pattern-recognition molecules (PRMs)
that recognize fragments of bacterial peptidoglycan. Nod1 rec-
ognizes D-glutamyl-meso-diaminopimelic acid, a peptido-
glycan-derived dipeptide found primarily in Gram-negative
bacteria as well as select species of Gram-positive bacteria,
including Listeria monocytogenes (Chamaillard et al., 2003;
Girardin et al., 2003a). Nod2 recognizes muramyl dipeptide
(MDP), which is present in both Gram-positive and Gram-
negative bacteria (Girardin et al., 2003b; Inohara et al., 2003).
Recruitment of Nod1 and Nod2 to the plasma membrane has
been reported, and these PRMs are thought to primarily detect
intracellular bacteria during the invasion process (Philpott and
Girardin, 2010). Indeed, Nod1 and Nod2 are critical in initiating
innate immune responses to Shigella flexneri (Shigella), Listeria
monocytogenes (Listeria), and Salmonella enterica serovar
Typhimurium (Salmonella) (Sorbara and Philpott, 2011).
Recognition of peptidoglycan motifs by Nod1 or Nod2 in the
cytosol leads to the recruitment of the adaptor protein Rip2 to
a complex of oligomerized Nod proteins, and this recruitment
then drives NF-kB- and MAPK-dependent inflammatory re-
sponses (Inohara et al., 2000; Ogura et al., 2001b). Activation
of Rip2 is critical for the recruitment of the IKK complex and other
downstream components of the Nod signaling pathway, and this
recruitment is controlled by the addition of K63-linked polyubi-
quitin on Rip2. Several E3 ligases, including XIAP, cIAP1,
cIAP2, ITCH, TRAF6, and TRAF2 and TRAF5, have been pro-
posed to drive the ubiquitination of Rip2 (Sorbara and Philpott,
2011).
ATG16L1 is a key component of the autophagy machinery.
Autophagy is a bulk degradation system in which cytoplasmic
cargo is sequestered in double-membrane autophagosomes
for subsequent degradation in lysosomes. ATG16L1 functions
in autophagy through its interaction with an ATG5-ATG12 conju-
gate to direct the site of autophagosome formation (Fujita et al.,
2008; Fujita et al., 2009; Mizushima et al., 2003). Recruitment of
ATG16L1:ATG5-ATG12 promotes the localized conversion of
LC3 to a phosphotidyl-ethanolamine-conjugated form, LC3-II,
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in restricting the growth of invasive bacteria has been described.
Infection with invasive pathogens such as Shigella, Listeria, or
Salmonella triggers an amino acid starvation stress response
(Tattoli et al., 2012b; Tattoli et al., 2013) that induces autophagy
as a host-mediated bactericidal mechanism (Birmingham et al.,
2007; Birmingham et al., 2006; Ogawa et al., 2005).
A critical role for Nod1 and Nod2 in the initiation and targeting
of anti-bacterial autophagy has been identified (Cooney et al.,
2010; Homer et al., 2010; Travassos et al., 2010). Stimulation
of Nod1 or Nod2 induces autophagosome formation, and both
Nod1 and Nod2 interact with ATG16L1 to target the autophagy
machinery to the plasma membrane at the site of bacterial
invasion (Travassos et al., 2010). In addition to functioning as a
bactericidal mechanism, Nod-induced autophagy also pro-
motes antigen presentation on MHC class II molecules (Cooney
et al., 2010). However, the impact of ATG16L1 interaction with
Nod1 and Nod2 on canonical Nod signaling and Nod-driven
inflammation during infection has not been elucidated.
Herewe have characterized the functional interaction between
ATG16L1 and Nod proteins and identified a previously unappre-
ciated role of ATG16L1 in specifically regulating Nod1 and Nod2
signaling. We demonstrate that ATG16L1 negatively regulates
Nod1- and Nod2-driven inflammation independently of its
canonical function in autophagosome formation. Moreover,
this Nod regulatory function of ATG16L1 was specific to this
autophagy protein given that autophagy interference by
silencing ATG5 or ATG9a or by chemical inhibition did not regu-
late Nod responses. The mechanism of Nod regulation by
ATG16L1 was the blocking of Rip2 activation, as marked by
reduced polyubiquitination of Rip2 and diminished incorporation
into Nod signaling complexes. Finally, cells expressing the CD
risk allele of ATG16L1 had defective regulation of Nod-driven
inflammation. Altogether, these findings extend the role of the
ATG16L1-Nod1 and -Nod2 axis beyond the targeting of bacteria
to the autophagy system and demonstrate that ATG16L1 has a
critical function in the control of Nod-driven inflammatory re-
sponses. Disruption of this regulation by ATG16L1 could cause
a predisposition to aberrant inflammation, as observed in CD.
RESULTS
Expression of an Autophagy-Deficient Truncation
of ATG16L1 Regulates Cytokine Responses
We aimed to determine whether the proteins of the autophagic
systems contributed to the host response to bacterial pathogens
independently of their ability to induce autophagy. In Atg5/
and ATG16L1 DCCD murine embryonic fibroblasts (MEFs),
which are defective in autophagy induction (Fujita et al., 2009;
Ogawa et al., 2005), rapamycin-induced LC3-II generation was
undetectable, as expected (Figure 1A). In addition, the amounts
of p62 were increased in the autophagy-deficient cell lines (Fig-
ure 1A), in line with the previous evidence that this protein is nor-
mally constitutively degraded by autophagy (Lee et al., 2012).
Next we infected the control and autophagy-deficient MEFs
with the invasive bacteria Shigella, Listeria, and Salmonella. As
previously reported, Atg5/ MEFs produced increased
amounts of the proinflammatory cytokine CXCL1 after Shigella
infection (Figure 1B) (Dupont et al., 2009). However, asIcompared to Atg5/ MEFs, ATG16L1 DCCD MEFs infected
with Shigella unexpectedly produced reduced amounts of
CXCL1 (Figure 1B). In the case of Salmonella and Listeria,
although these pathogens did not trigger increased secretion
of CXCL1 in Atg5/ cells as compared to WT cells, the cytokine
response observed in ATG16 DCCD MEFs was significantly
blunted in comparison to the response in either WT or Atg5/
cells. Together, these results reveal an unanticipated difference
between Atg5/ and ATG16L1 DCCD cells with regard to the
response to invasive bacterial pathogens and imply that a
macroautophagy-independent function of ATG16L1 contributes
to the cytokine response to these pathogens.
Although autophagy deficient, the ATG16L1 DCCD MEFs do
express a truncated form of ATG16L1 lacking amino acids
70–212 (Figures 1C and 1D), and we thus hypothesized that
the expression of this truncated ATG16L1 protein might be the
cause of the differential cytokine response observed in Atg5/
and ATG16L1 DCCD MEFs. In order to examine this possibility,
we knocked down expression of the DCCD fragment in the auto-
phagy-deficient MEFs by using shRNA directed against a region
in the remaining fragment of ATG16L1, and we confirmed the
efficiency of the knockdown at the protein and RNA levels (Fig-
ures 1E and 1F). Knockdown of the DCCD fragment in
ATG16L1 DCCD MEFs resulted in an increased secretion of
CXCL1 in response to Listeria andSalmonella and a trend toward
an increased response to Shigella (Figure 1G). Thus, a domain
of ATG16L1, distinct from the coiled-coil region implicated
in autophagy, was responsible for controlling the cytokine
response to bacterial pathogens.
ATG16L1, but not ATG5, Regulates the Cytokine
Response to Invasive Bacterial Pathogens in Epithelial
Cells
Shigella, Listeria, and Salmonella are enteric pathogens that,
during infection in vivo, are able to invade intestinal epthelial cells
and replicate intracellularly. On the basis of our findings in fibro-
blasts, we sought to establish a model system to investigate the
respective roles of ATG5 and ATG16L1 in intestinal epithelial
cells during bacterial infection. We took the approach of tran-
siently knocking down these transcripts in ModeK mouse intes-
tinal epithelial cells to minimize the accumulated effects from the
prolonged loss of autophagy on essential cellular metabolic pro-
cesses. Knockdown of ATG5 or ATG16L1 was confirmed at the
protein andmRNA levels (Figures S1A, S1B, and S1C in the Sup-
plemental Information available with this article online). As ex-
pected, ATG5 or ATG16L1 deficiency led to impaired conversion
of endogenous LC3-I to LC3-II after rapamycin treatment (Fig-
ure S1E), and defective targeting of intracellular Shigella to
GFP-LC3+ autophagosomes (Figures S1G and S1H). This
demonstrated that the knockdown procedure not only reduced
amounts of ATG5 or ATG16L1 but also effectively blocked auto-
phagy induction in ModeK cells. In contrast to the chronic auto-
phagy-deficient conditions in the autophagy-deficient MEFs
(Figure 1A), we did not observe a change in p62 amounts by pro-
tein blot after transient knockdown (data not shown), thus
excluding reported confounding effects of changes in p62
amounts on inflammatory responses. Knockdown of ATG16L1
but not ATG5 triggered a significant upregulation of CXCL1
secretion after infection with Shigella (Figure 2A), Listeriammunity 39, 858–873, November 14, 2013 ª2013 Elsevier Inc. 859
Figure 1. An Autophagy-Deficient Fragment
of ATG16L1 Regulates the Cytokine
Response to Bacterial Infection in MEFs
(A) Wild-type, Atg5/, or ATG16L1DCCD MEFs
stimulated with rapamycin (25 mg/ml) for 2 hr and
amounts of LC3, p62, and tubulin were analyzed by
protein blot.
(B) MEFs were infected with Shigella, Listeria, or
Salmonella, and CXCL1 production was measured
16 hr after infection (n = 3).
(C) Schematic depiction of the truncated ATG16L1
expressed in DCCD MEFs.
(D) Expression of the DCCD fragment was
confirmed by protein blot.
(E and F) Knockdown of the DCCD fragment in
ATG16L1 DCCD MEFs transduced with ATG16L1
targeting shRNA was examined by protein blot (E)
or qPCR (F, n = 6).
(G) Control or DCCD knockdown ATG16L1DCCD
MEFs were infected with Shigella, Listeria, or
Salmonella, and CXCL1 was measured 16 hr after
infection (n = 3, from a representative experiment).
Protein blots in (A), (D), and (E) are representative of
three independent experiments. Values shown are
means + SEM. *p < 0.05, **p < 0.01 by one-way
ANOVA and Tukey post-test (B) or t test (F and G).
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obtained in MEFs (see Figure 1). As a control, we also observed
that blocking autophagosome maturation with chloroquine
in ModeK cells did not increase cytokine responses to Shigella
infection, despite chloroquine-dependent accumulation of
LC3-II (Figures 2D–2F).
We also knocked down expression of ATG16L1 in human
epithelial MDAMC cells and confirmed at the protein and RNA
level that ATG16L1 expression was silenced (Figures S1I
and S1J). Similar to mouse epithelial cells, MDAMC cells860 Immunity 39, 858–873, November 14, 2013 ª2013 Elsevier Inc.experiencing a loss of ATG16L1 showed
an increased IL-8 response to invasive
Shigella infection (Figure 2G), indicat-
ing that human ATG16L1 also sup-
presses cytokine responses after bacterial
infection.
Thus, in line with the findings in the auto-
phagy-deficient DCCD MEFs, ATG16L1
has a regulatory role in bacteria-infected
murine and human epithelial cells, and
this role is independent from its function
in macroautophagy.
ATG16L1Regulates theResponse to
Cytosol- Exposed Pathogens
We next sought to determine whether
ATG16L1 was a general negative regulator
of the response to bacterial infection or
whether it regulated signaling within spe-
cific cellular compartments. Both Shigella
and Listeria induce uptake into epithelial
cells and subsequently escape from the
entry endosome into the cytosol. Todetermine whether cytosol-exposure was necessary for the
increased cytokine response to Shigella or Listeria in
ATG16L1-deficient ModeK cells, we performed infections with
noninvasive Shigella or endosome-confined Listeria. Whereas
ATG16L1 expression regulated inflammatory responses to
cytoinvasive strains, it had no impact on cytokine responses
to noninvasive Shigella (Figure 3A) or the endosome-confined
Listeria strain (Figure 3B) at either 8 or 16 hr after infection.
Indeed, significant increases in the production of CXCL1 with
cytoinvasion of Shigella or Listeria as compared to noninvasive
Figure 2. ATG16L1 Negatively Regulates
the Epithelial Cell Response to Invasive
Bacteria in an Autophagy-Independent
Manner
(A–C) Production of CXCL1 by ModeK cells
transduced with the indicated shRNAs was
measured 16 hr after infection with Shigella (A),
Listeria (B), or Salmonella (C) (n = 3, values are
expressed as an n-fold change relative to
uninfected controls).
(D) ModeK cells were treated with chloroquine
(10 mM) and rapamycin (25 mg/ml) as indicated,
and formation of LC3-II was monitored by pro-
tein blot.
(E and F) Control or chloroquine-treated cells were
infected with invasive Shigella, and production of
CXCL1 (E) or CXCL2 mRNAs (F) was measured by
qPCR (n = 4).
(G) Control and ATG16L1 knockdown MDAMC
cells were infected with Shigella for 16 hr, and
secretion of IL-8 was measured by ELISA (n = 8).
Values shown are means + SEM. *p < 0.05,
**p < 0.01 by one-way ANOVA and Tukey post-test
(A–C) or t test (G). See also Figure S1.
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knockdown cells but not in control or ATG5 knockdown cells
(Figure S2A).
In contrast to the cytosolic localization of Shigella and Listeria,
Salmonella replicates within a modified vacuole, termed the
Salmonella-containing vacuole (SCV). Despite its vacuolar repli-
cation site, early bacterial modification of the maturing endo-
some and insertion of type III secretion systems into the vacuole
membrane result in partial cytosolic exposure of Salmonella or
Salmonella-derived molecules early during infection, leading to
the targeting by the autophagymachinery and activation of intra-
cellular PRRs at early time points (Birmingham et al., 2006). AsImmunity 39, 858–873, Nwith Shigella and Listeria, ATG16L1 also
regulated the response to Salmonella at
8 hr (Figure 3C) in addition to 16 hr after
infection (Figure 2C). These results sug-
gest that the cytosolic exposure that
occurs during the remodeling of the SCV
by Salmonella is sufficient to trigger an
ATG16L1-regulated cytokine response
pathway. To directly test this hypothesis,
we utilizedDSPI-1/pInv, a SPI-1-deficient
Salmonella strain expressing the Invasin
protein from Yersinia. This strain is able
to invade epithelial cells but does not
trigger the same membrane damage,
cytosolic exposure, or autophagy target-
ing as wild-type Salmonella (Birmingham
et al., 2006; Tattoli et al., 2012a). In
contrast to infection with wild-type
Salmonella, infection of ATG16L1 knock-
down cells with the DSPI-1/pInv strain
did not lead to an enhanced cytokine
response (Figure 3D). Together, these
results demonstrate that ATG16L1 nega-tively regulates cytokine responses to invasive bacteria that
are presented to the host cytosol.
We next aimed to investigate whether ATG16L1-dependent
blunting of cytokine secretion during cytoinvasive bacterial
infection occurred at the transcriptional or posttranscriptional
level. We observed that knockdown of ATG16L1 led to
enhanced induction of CXCL1 and CXCL2 mRNA after infec-
tion with invasive but not noninvasive Shigella (Figure 3E),
with wild-type but not endosome-confined Listeria (Figure 3F),
and with Salmonella (Figure 3G). Thus, ATG16L1 regulates
cytokine responses to intracellular bacteria at the transcrip-
tional level.ovember 14, 2013 ª2013 Elsevier Inc. 861
(legend on next page)
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directly by PRR activation, ATF3 is a key stress-response-
pathway component that can be induced by membrane damage
andwhich probably does not require PRR activation for its induc-
tion (Tattoli et al., 2012b). In order to determine whether
ATG16L1 regulated all pathways downstream of membrane
damage and cytosol exposure, we examined ATF3 induction in
ATG16L1-deficient ModeK cells (Figure 3H). As expected, infec-
tion with cytoinvasive strains of Shigella, Listeria, and Salmonella
triggered ATF3 activation 3 hr after infection; however, unlike the
proinflammatory cytokine response, silencing of ATG16L1
expression did not result in increased ATF3 activation. Thus,
ATG16L1 specifically suppressed transcriptional pathways lead-
ing to cytokine production after pathogen entry into the cytosol.
In addition, the increased cytokine responses in ATG16L1
knockdown cells did not depend on increased bacterial replica-
tion; increased responses were still observed when replication of
Shigella was blocked with chloramphenicol (Figures S2B and
S2C) or when a DphoP Salmonellamutant that invades epithelial
cells but is attenuated in the intracellular environment was used
(Figure S2D).
ATG16L1 Negatively Regulates Nod1- and Nod2-Driven
Cytokine Responses
We next aimed to identify the mechanism through which
ATG16L1 negatively regulates cytokine responses to invasive
bacterial pathogens. ATG16L1 interacts with Nod1 and Nod2
to target the autophagic response to invading bacteria (Travas-
sos et al., 2010). We speculated that this interaction could
also be responsible for the autophagy-independent modulation
that we observed for cytokine responses in MEFs and epithelial
cells. The truncated ATG16L1 found in autophagy-deficient
ATG16L1 DCCD MEFs bound to Nod1 (Figure 4A left panels)
and Nod2 (Figure 4A right panels) with a similar efficiency as
full-length ATG16L1. Furthermore, Nod1 and Nod2 also bound
to the ATG16L1’s C-terminal region (amino acids 230–607) that
does not interact with ATG5 (data not shown), suggesting that
the interaction occurred through the ATG16L1 WD40 repeat
region.
In order to show that ATG16L1 limits Nod-dependent
responses, we first stimulated ATG16L1 DCCD MEFs with the
Nod1 ligand C12-iE-DAP. Knocking down the DCCD fragment
of ATG16L1 resulted in an increased cytokine response to the
Nod1 agonist but not LPS (Figure 4B), thus highlighting the
specificity of ATG16L1-dependent regulation of inflammatory
signaling. Because the ATG16L1 DCCD MEFs are autophagy
deficient, these results also imply that ATG16L1 affects
Nod1-dependent signaling through autophagy-independent
pathways.Figure 3. ATG16L1 Suppresses the Cytokine Response to Cytoinvasiv
(A–H)White bars indicate scrambled shRNA cells, and black bars indicate respons
were infected with (A) invasive or noninvasive Shigella and with (B) Listeria or th
infection. (C) At 8 hr after Salmonella infection, CXCL1 was measured in control an
ModeK cells were infected with wild-type Salmonella or the DSPI-1/pInv strain, a
mRNA was measured 3 hr after infection with invasive or noninvasive Shigella (E),
Control or ATG16L1 silenced ModeK cells were infected with the indicated strain
(n = 4). All values are expressed as an n-fold change relative to each cell-type ba
Figure S2.
IIn epithelial cells, we similarly observed that the knockdown of
ATG16L1 in human MDAMC cells resulted in specific upregula-
tion of the response to Nod1 ligand but not to LPS or TNF-a (Fig-
ure 4C). In ModeK cells, which contrary toMEFs orMDAMC cells
express both Nod1 and Nod2 and respond to the Nod2 ligand
L18-MDP, we similarly observed that the knockdown of
ATG16L1 resulted in specific upregulation of the response to
both Nod ligands but not to LPS or TNF-a (Figure 4D). As a
control, we also aimed to confirm that the effect of ATG16L1
on Nod-driven signaling was independent of autophagy in
ModeK epithelial cells. Silencing of ATG5 did not alter responses
to direct Nod stimulation (Figure S3A). Indeed, ATG5 knockdown
cells had a similar ligand response profile as control cells (Fig-
ure S3B). Importantly, ATG16L1 knockdown cells had similar
CXCL1 production after TNF-a or LPS stimulation but had a
greater response to Nod1 or Nod2 stimulation compared than
did ATG5 knockdown cells (Figure S3B). Similar to that of
ATG5, silencing of ATG9a (Figures S1A and S1D) did not trigger
increased responses to Nod1 or Nod2 stimulation (Figure S3C),
despite functional inhibition of autophagy (Figure S1F). Finally,
treatment with the autophagy inhibitor 3-MA did not alter
cytokine production after Nod1 or Nod2 stimulation (Figure S3D).
To confirm that the changes in Nod responses were not due to
off-target effects of the ATG16L1 murine or human shRNAs, we
generated additional shRNAs targeting murine ATG16L1 and
tested them in ModeK cells. Three of the shRNAs silenced
ATG16L1 expression at the protein and RNA levels (Figures
S3E and S3F), whereas one did not successfully knock down
ATG16L1. In agreement, all three shRNAs that silenced
ATG16L1 resulted in increased Nod2 but not LPS responses in
comparison to those in control cells, whereas the inefficient
shRNA failed to alter Nod2 responses (Figure S3G).
Thus, ATG16L1 specifically inhibits Nod-dependent re-
sponses in MEFs and epithelial cells.
ATG16L1 Modulates the Cytokine Response to Bacteria
through Nod Signaling
Infection with Shigella, Listeria, or Salmonella results in the
activation of multiple PRRs, which could contribute to the
increased cytokine response in ATG16L1-deficient cells. We
next determined whether ATG16L1 modulated host responses
to bacterial pathogens solely through the Nod1- or Nod2-Rip2
signaling axis. To do so, we knocked down ATG16L1 in primary
MEFs from WT and Ripk2/ mice (Figure 4D). Although reduc-
tion of ATG16L1 expression led to an increased CXCL2 response
to invasive Shigella in WT MEFs (Figure 4E), this increase was
fully Rip2 dependent given that ATG16L1 silencing even
appeared to downregulate CXCL2 in infected Ripk2/ MEFs.
Thus, ATG16L1-dependent blunting of proinflammatorye Bacteria
es in ATG16L1 knockdown cells. Control or ATG16L1 knockdownModeK cells
e endosome-confined mutant, and CXCL1 was measured at 8 and 16 hr after
d ATG16L1 knockdown cells. (A–C, n = 4). (D) Control or ATG16L1 knockdown
nd CXCL1 was measured 16 hr after infection (n = 9). (E–G) CXCL1 and CXCL2
wild-type or endosome-confined Listeria (F), or Salmonella (G) (E–G, n = 6). (H)
s, and production of ATF3 mRNA was analyzed by qPCR at 3 hr after infection
seline and are shown as means + SEM. *p < 0.05, **p < 0.01 by t test. See also
mmunity 39, 858–873, November 14, 2013 ª2013 Elsevier Inc. 863
Figure 4. ATG16L1 Negatively Regulates Nod1- and Nod2-Driven Cytokine Responses
(A) HEK293T cells were transfectedwith HA-Nod1 (left) or HA-Nod2 (right) and Flag-mCherry, Flag-ATG16L1, or Flag-DCCD. Interaction between the Flag-tagged
proteins and Nod1 or Nod2was assessed by immunoprecipitation. Input lysates and immunoprecipitated proteins were probed for Flag and HA (a representative
of two independent experiments is shown).
(legend continued on next page)
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the control of Nod-driven pathways.
In intestinal epithelial cells, we used a specific Rip2 inhibitor to
determine whether ATG16L1 restricted Rip2-dependent
signaling during infection. As expected, treatment with 1 mM of
the Rip2 inhibitor efficiently blocked CXCL1 production induced
by the Nod ligands C12-iE-DAP and L18-MDP without blocking
the response to TNF-a or LPS (Figure S3H). In addition, treat-
ment with the Rip2 inhibitor did not block Shigella invasion or
replication (data not shown). In agreement with the data from
fibroblasts, treatment with the Rip2 inhibitor in ATG16L1 knock-
down intestinal epithelial cells blocked the increased CXCL2 and
CXCL1 mRNA response to invasive Shigella without impacting
the response to the noninvasive strain (Figures 4F and
4G). Thus, ATG16L1 specifically suppressed proinflammatory
responses mediated by Nod1 and Nod2.
ATG16L1 Negatively Regulates the Activation of Rip2
and Its Incorporation in Large Signaling Complexes
We next sought to determine at which step of the Nod1 and
Nod2 signal transduction pathway ATG16L1 exerts its regulatory
function. Because stimulation of either Nod1 or Nod2 leads to
the activation of NF-kB, we employed an NF-kB-luciferase re-
porter. Knockdown of ATG16L1 led to enhanced NF-kB activa-
tion after stimulation with Nod1 or Nod2 ligands but not TNF-a
(Figure 5A), thus showing that ATG16L1 negatively regulated
Nod1 and Nod2 signaling upstream of or at the level of NF-kB
activation.
Upstream of Nod-activated NF-kB, the activation of Rip2 is
controlled by the addition of K63-linked polyubiquitin. Therefore,
we asked whether the presence of ATG16L1 affected Nod-
induced ubiquitination of Rip2. In human embryonic kidney
293T HEK293T cells expressing both Nod1 and ubiquitin,
stimulation with the Nod1 ligand C12-iE-DAP triggered Rip2
polyubqitination, detected as an increase in high-molecular-
weight Rip2 and K63-ubiquitin after Rip2 immunoprecipitation
(Figure 5B; compare lanes 1 and 2, middle and right panels).
Importantly, overexpression of ATG16L1 blocked the Nod1-
dependent K63-linked poly-ubiquitination of Rip2 (Figure 5B;
compare lanes 2 and 4, middle and right panels). Therefore,
ATG16L1 inhibits Nod-dependent signaling at the level of or up-
stream of Rip2 ubiquitination.
Initiation of Nod signaling is thought to occur through recruit-
ment of the Rip2 adaptor into a large Nod signaling complex,
or Nodosome. We next asked whether ATG16L1 regulated the
incorporation of Rip2 into the Nodosome and used sucrose
gradient centrifugation to track macromolecular complex forma-
tion, as was recently reported in the case of MAVS (Hou et al.,(B) CXCL1wasmeasured 16 hr after stimulation of control andDCCD knockdown
representative experiment).
(C) IL-8 production by control or ATG16L1-knockdownMDAMC cells wasmeasur
(100 ng/ml) (n = 3).
(D) CXCL1 production was measured after 16 hr of stimulation of control and
(20 mg/ml), TNF-a (10 ng/ml), or LPS (100 ng/ml) (n = 3–8).
(E) ATG16L1 mRNA levels in control and knockdown wild-type and Ripk2/ kno
(F) After 3 hr infection with Shigella, CXCL2 was measured in control and knockd
(G and H) CXCL2 (G) and CXCL1 (H) mRNAs were measured in control and ATG
Shigella in the presence or absence of 1 mMof Rip2 inhibitor (a representative of tw
n-fold changes relative to unstimulated controls. Values shown are means + SEM
I2011). HEK293T cells transiently expressing Nod1 were trans-
fected with ATG16L1 or a control vector, and cell lysates were
separated by sucrose gradient ultracentrifugation after Nod1
stimulation. As expected, stimulation of control cells with Nod1
ligand led to a shift of Rip2 signal into more dense fractions,
indicative of the incorporation of Rip2 into larger complexes (Fig-
ure 5C). Interestingly, overexpression of ATG16L1 resulted in a
shift of Rip2 toward smaller fractions before and after Nod1 stim-
ulation (Figure 5C). It must be noted that ATG16L1 overexpres-
sion affected the Nodosome even in the absence of the Nod1
ligand C12-iE-DAP; this most likely reflects the fact that Nod1
overexpression is in itself sufficient to trigger formation of a No-
dosome and activation of downstream signaling, as previously
shown (Inohara et al., 2000).
To confirm the above results by using an endogenous system,
we infected control or ATG16L1 knockdown ModeK cells with
Shigella (Figure 5D). Knockdown of ATG16L1 led to a shift of
Rip2 into denser fractions after infection, consistent with the
increased Nod-driven signaling in these cells. Moreover, the
accumulation of Rip2 into denser fractions was dependent on
bacterial invasion; noninvasive Shigella did not trigger this shift
in ATG16L1 knockdown cells (Figure 5E).
Thus, ATG16L1 functions at the initial steps of the Nod1 and
Nod2 signaling pathway to negatively regulate the activation of
Rip2 and its incorporation into Nodosomes.
The Roles of ATG16L1 in Nod Regulation and Autophagy
Can Be Molecularly Decoupled
We next asked whether the Nod-regulatory function of ATG16L1
could be separated at amolecular level from its role in autophagy
induction. To address this, we generated an ATG16L1 truncated
form lacking the first 84 amino acids. The 85–607-truncated form
of ATG16L1 lacks the N-terminal region necessary for ATG5
binding (Mizushima et al., 2003), yet it is still able to bind Nod1
or Nod2 (Travassos et al., 2010) (Figure 6A). We first verified
this and found that, indeed, the 85–607-truncated ATG16L1
mutant did not bind to ATG5 but still interacted with Nod1 and
Nod2 (Figures S4A and S4B), in agreement with our data sug-
gesting that Nod proteins interacted with the C-terminal portion
of ATG16L1 (see Figure 4). We next established a knockdown-
reconstitution system in which endogenous ATG16L1 was effi-
ciently depleted with an shRNA targeting the 30-UTR of human
ATG16L1 (Figure 6B, top panel), and we then re-expressed frag-
ments of ATG16L1 by lentiviral transduction. ATG16L1 knock-
down cells were rescued with Flag-mCherry or with Flag-tagged
constucts of either full-length ATG16L1 or the 85–607 truncation.
Rescue of ATG16L1 knockdown was confirmed at both the pro-
tein and RNA levels (Figures 6B and 6C). We then examined theATG16L1DCCDMEFswith 20 mg/ml C12-iE-DAP or 100 ng/ml LPS (n = 3 from a
ed after 16 hr stimulation with C12-iE-DAP (20 mg/ml), TNF-a (1 ng/ml), and LPS
ATG16L1-knockdown ModeK cells with C12-iE-DAP (20 mg/ml), L18-MDP
ckout MEFs.
own MEFs (n = 6).
16L1 knockdown ModeK cells infected for 10 hr with invasive or noninvasive
o independent experiments is shown). Values forModeK cells are presented as
. *p < 0.05, **p < 0.01 by t test. See also Figure S3.
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Figure 5. ATG16L1 Regulates the Formation of the Nod Signaling Complex
(A) NF-kB activation in control and ATG16L1-knockdown ModeK cells followed a 4.5 hr stimulation with C12-iE-DAP (10 or 50 mg/ml), L18-MDP (10 mg/ml), or
TNF-a (10 ng/ml) (n = 3-5). Values are normalized to their respective unstimulated controls and are presented as means + SEM. *p < 0.05 by t test.
(B) Rip2 was immunoprecipitated from Nod1- and ubiquitin-overexpressing HEK293T cells also transfected with ATG16L1 or pcDNA3 and stimulated with C12-
iE-DAP (1 mg/ml) for 30 min. Ubiquitinated Rip2 was revealed by blots for Rip2 and K63-ubiquitin, and high-molecular-weight Rip2 and K63 are indicated with a
bracket.
(C and D) Rip20s incorporation into large complexes was assessed by sucrose-gradient ultracentrifugation after stimulation of ATG16L1- or control-cotransfected
Nod1-expressing HEK293T cells with C12-iE-DAP (1 mg/ml) for 30 min (C), infection of control and ATG16L1-knockdownModeK cells with Shigella for 30 min (D),
and infection of ATG16L1-knockdown ModeK cells with invasive or non-invasive Shigella for 30 min (E). Fractions were collected and blotted for Rip2. Arrows
indicate the most dense fraction with Rip2 signal. Data presented in (B)–(E) are representative images from 2–3 independent experiments.
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ATG16L1 Negatively Regulates Nod1 and Nod2ability of these ATG16L1 fragments to rescue autophagy induc-
tion. As expected, rescue with full-length ATG16L1 restored tar-
geting of intracellular Shigella to autophagosomes (Figures 6D
and 6E). In contrast, re-expression of the 85–607 truncation,
which is unable to interact with ATG5 (see Figure S4A), rescued
neither autophagy targeting of Shigella (Figures 6D and 6E) nor
rapamycin-induced accumulation of LC3 puncta (data not
shown). We then characterized how these fragments affected
cytokine responses after invasive bacterial infection. Re-expres-
sion of the full-length ATG16L1 reduced the enhanced cytokine
response observed in ATG16L1 knockdown cells after Shigella
infection by 32.8% ± 7.0% (Figure 6F). The partial rescue
observed is most likely explained by the heterogenous re-
expression of ATG16L1 by transient transduction in knockdown
cells. In contrast, re-expression of a general autophagy-compe-
tent N-terminal fragment of ATG16L1 containing amino acids
1–230 was unable to rescue the cytokine response (data not
shown). Finally, the 85–607 fragment was able to reduce the
exacerbated cytokine response by 55.6% ± 5.2%, despite its
being unable to rescue autophagy induction (Figure 6F). Thus,
although the N-terminal region of ATG16L1 (ATG5-binding and
coiled-coil domains) is required for autophagy induction, the
C-terminal region containing the WD40 repeats mediates the
modulation of Nod signaling.
Nod-Driven Inflammatory Responses Are Dysregulated
in Cells Expressing the 300A* Variant of ATG16L1
A SNP with a threonine-to-alanine substitution at position 300 of
ATG16L1 is associated with the development of CD. Although
this polymorphism has reproducibly been linked to CD, the two
alleles are present at approximately equal proportions in healthy
controls, indicating that this polymorphism probably plays a
modifying role in CD rather than being a primary driver of disease
development. To investigate the effect of the 300A SNP during
bacterial infection, we again used a knockdown-reconstitution
system to re-express either ATG16L1 300T or 300A variants in
the human epithelial MDAMC cells (Figures 6A and 6B). Both
variants of ATG16L1 were able to rescue anti-bacterial auto-
phagy (Figures 6C and 6D), in agreement with a previous report
(Fujita et al., 2009). Having uncovered a regulatory role for
ATG16L1 in the Nod-driven cytokine response, we next asked
whether cells expressing the 300A risk variant had altered Nod
signaling in response to bacterial infection. Re-expression of
the 300T variant resulted in a partial rescue of the enhanced
IL-8 response induced by Shigella in ATG16L1 knockdown cells
(26.9% ± 4.0%) (Figures 7E and 7F), in line with the results
obtained above (see Figure 6F). Interestingly, similar reconstitu-
tion with the CD-associated variant 300A failed to rescue the
exaggerated IL-8 expression induced by Shigella in ATG16L1
knockdown cells. Together, these observations suggest that
the ATG16L1 300A variant displays a blunted capacity to
mitigate Nod-dependent proinflammatory signaling, which could
contribute to heightened inflammation in CD-affected individuals
carrying this SNP.
DISCUSSION
In addition to their function in driving proinflammatory cytokine
production, Nod1 and Nod2 interact with ATG16L1, which is crit-Iical for the early targeting of intracellular Shigella and Salmonella
to autophagosomes for degradation in the lysosome compart-
ment (Cooney et al., 2010; Travassos et al., 2010). Moreover,
direct stimulation of Nod1 and Nod2 by muramyl peptides or
peptidoglycan can initiate autophagosome formation (Cooney
et al., 2010; Homer et al., 2010; Travassos et al., 2010). Here,
we have shown that the interaction of ATG16L1 with Nod1 or
Nod2 negatively regulates their signaling. We showed that
ATG16L1 functions at an upstream step of the Nod signaling
pathway by negatively regulating the activation of Rip2 and the
incorporation of Rip2 into large Nodosome complexes. Unex-
pectedly, this Nod-regulatory capacity of ATG16L1 was inde-
pendent of its role in canonical autophagy. Finally, we observed
that the capacity of ATG16L1 to modulate Nod signaling was
impaired with the expression of the CD-associated allele of
ATG16L1. Thus, our results on ATG16L1 unveil an unanticipated
nonautophagic function of a protein from the core autophagic
machinery and support an emerging paradigm for distinct
biological processes (see also below). Because NOD2 and
ATG16L1 are susceptibility genes for CD, these observations
will also contribute to the understanding of the etiology of this
disease.
A growing body of evidence shows that the critical function of
Nod1 and Nod2 occurs at the point where membrane integrity is
initially breached and peptidoglycan fragments enter the cytosol,
either through the actions of type III or type IV secretion systems
or through bacterial invasion (Philpott and Girardin, 2010).
ATG16L1 also localizes in proximity to the plasma membrane
through its interaction with the heavy chain of clathrin (Raviku-
mar et al., 2010). Importantly, Nod1 and Nod2 direct autophagy
by recruiting ATG16L1 to the plasma membrane at the site of
bacterial entry (Travassos et al., 2010). Our findings extend this
model by demonstrating that significant regulation of the Nod-
driven response also occurs at an early time point, most likely
at this membrane-signaling node within the cell. ATG16L1 spe-
cifically regulated the cytokine response to cytosol-exposed
strains of Shigella and Listeriawithout affecting cytokine produc-
tion triggered by infection with noninvasive Shigella or endo-
some-confined Listeria strains. In addition, ATG16L1 regulated
the cytokine response to wild-type Salmonella infection that
triggers cytosol exposure during SCV remodeling, but it did not
regulate the response to an invasive yet SPI-1-deficient strain
that does not trigger cytosol exposure. In agreement with an
early regulatory role for ATG16L1, blocking Shigella replication
30 min after infection did not affect the dysregulation of
Nod-driven signaling in ATG16L1-deficient cells, and changes
in the activation of Rip2 and complex formation were observed
as early as 30 min after infection or stimulation, in agreement
with our previous studies (Girardin et al., 2001). These findings
suggest that Nod signaling is initiated and regulated within this
early time point after infection. In addition, Nod1 and Nod2 are
able to recruit ATG16L1 to the plasma membrane without coloc-
alization of ATG5 (Travassos et al., 2010) and are able to interact
with ATG16L1 constructs that lack ATG5 binding (Figure S4).
Overall, the results presented here suggest that there exists,
prior to recruitment of the autophagy machinery, an early step
at which ATG16L1 efficiently limits the activation of the Nod1
and Nod2 signaling pathway independently of its subsequent
role in targeting autophagosome formation. Importantly, and asmmunity 39, 858–873, November 14, 2013 ª2013 Elsevier Inc. 867
Figure 6. The Nod-Regulatory Function of ATG16L1 Can Be Separated from Its Role in Autophagosome Formation
(A) Schematic depiction of ATG16L1 and the 85–607, 1–230, and DCCD truncations, The sites amplified by ATG16L1 PCR 1 and 2 are shown.
(B) ATG16L1 levels in control and ATG16L1 30-UTR shRNA knockdown MDAMC cells were examined by protein blot (top). Rescue with the indicated fragments
was analyzed by Flag blot (bottom).
(C) Expression of the ATG16L1 N-terminal (PCR 1), and coiled-coil domains (PCR 2) in control and rescued cells was analyzed by qPCR. Data presented in (B) and
(C) are representative of three independent experiments.
(legend continued on next page)
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events are those that are improperly regulated by the ATG16L1
CD-associated variant.
Previous reports have suggested an induced-proximity Nod
signalingmodel in which oligomerization of Nod1 or Nod2 results
in the recruitment of Rip2 (Inohara et al., 2000; Ogura et al.,
2001b). Our results from sucrose gradient fractionations provide
biochemical evidence in support of this model. In both overex-
pression and knockdown conditions, ATG16L1 was found to
negatively regulate this process. Currently, it remains unclear
whether the ubiquitination of Rip2 occurs prior to or subsequent
to its recruitment to a large Nod-dependent scaffold andwhether
ATG16L1 negatively regulates the incorporation of Rip2 into the
complex or acts indirectly by controlling the recruitment of a
tertiary factor required for the activation and/or retention of
Rip2 within a signaling complex. Disentangling this process will
provide insight both into the Nod signaling pathway and into
the fine regulatory mechanisms dependent on ATG16L1.
Autophagy is emerging as one of the critical effector mecha-
nisms of the immune response. Indeed, autophagy contains
intracellular bacteria and delivers them to the lysosome to pro-
mote clearance from infected cells. In addition, autophagy can
influence other processes of the immune response and immune
homeostasis, including antigen presentation (Cooney et al.,
2010; Lee et al., 2010), inflammasome activation (Harris
et al., 2011; Nakahira et al., 2011; Saitoh et al., 2008; Zhou
et al., 2011), and Paneth cell function (Cadwell et al., 2008; Witt-
kopf et al., 2012), among others (Deretic, 2011). In line with a
critical function of autophagy in immunity, the interaction of
ATG16L1 with Nod1 and Nod2 allows for the targeting of
intracellular bacteria to autophagosomes. Unexpectedly, we
observed that the Nod-regulatory function of ATG16L1 to
suppress inflammation was independent of its canonical role in
autophagy induction. These findings support a growing body
of evidence that, in the course of initiating autophagy, autophagy
proteins can have ancillary functions that are independent from
their canonical roles in autophagosome formation. Indeed, the
ATG5-12 conjugate regulates RIG-I signaling (Jounai et al.,
2007), and ATG9a regulates the association of STING with
TBK1 (Saitoh et al., 2009). An autophagosome-independent
function of ATG16L1 in hormone secretion has also been identi-
fied (Ishibashi et al., 2012). Furthermore, recent work has
implicated ATG7 and the ATG16L1:ATG5-ATG12 complex in
an autophagy-independent function negatively regulating
murine norovirus replication, thus further demonstrating that
subsets of autophagy proteins can also be co-opted for nonau-
tophagosome functions in the immune response (Hwang et al.,
2012). In this regard, it is interesting to notice that only the
N-terminal region of ATG16L1 is required for core autophagy
regulation, as evidenced by the fact that yeast ATG16 lacks
the C-terminal WD40 repeat domain. It is thus possible that the
presence of the WD40 repeat domain in the ATG16 ortholog of
higher eukaryotes conferred additional functions, such as the
regulation of Nod signaling in mammalian cells, to this protein.(D and E) Targeting of Shigella (DAPI, blue) to autophagosomes (GFP-LC3, green
images are shown in (D), and targeting was quantified (E) (n = 3).
(F) IL-8 mRNA wasmeasured 4.5 hr after infection with Shigella in control and resc
See also Figure S4.
ICD results from the dysregulation of the mucosal immune sys-
tem and the consequent hyperactivation of inflammatory path-
ways. Clearly, multiple triggers, both environmental and genetic,
are responsible for the initiation of disease. Our results demon-
strate that the link between two CD-susceptibility genes,
NOD2 and ATG16L1, goes beyond the targeting of microbes
for degradation or antigen presentation and directly affects the
inflammatory response to infection. Several defects associated
with the T300A allele of ATG16L1, including defective MDP-
induced autophagy in DCs (Cooney et al., 2010) and lympho-
blasts (Travassos et al., 2010), have been reported in human
cells. In in vitro reconstitution systems, some groups have
reported defective targeting of Salmonella in cells expressing
the 300A allele (Kuballa et al., 2008), whereas others have
reported no difference (Fujita et al., 2009). In our reconstitution
system, both the 300T and 300A alleles of ATG16L1 equally
rescued targeting of Shigella to autophagosomes. The discrep-
ancies in these findings might result from differences in the
sensitivity of the reconstitution systems to endogenously ex-
pressed ATG16L1, as well as from differences between initiating
autophagy with direct stimulation of Nod2 or infection with bac-
teria that may trigger autophagy through multiple pathways.
Our results support the notion that the CD-associated
ATG16L1 variant causes an improper control of inflammatory
signaling dependent on Nod1 and Nod2 activation given that
we observed that the ATG16L1 300A variant displayed an altered
capacity to downregulate Nod-dependent proinflammatory
signaling. These findings provide a molecular mechanism in
support of the observations by Plantinga et al., who reported,
in human PBMCs from donors homozygous for the T300A allele
of ATG16L1, increased cytokine production specifically in
response to Nod2 but not TLR2 or TLR4 ligand stimulation (Plan-
tinga et al., 2011). Importantly, our results provide further
evidence that Nod2, which is strongly linked to CD development,
and ATG16L1 are functionally linked in cell signaling cascades
that are improperly regulated in CD. In agreement, recent work
has demonstrated that ATG16L1 hypomorphic mice have a
hyperimmune phenotype that protects them from Citrobacter
infection and that the protective hyperimmune phenotype is
lost in mice doubly deficient for Nod2 and Atg16L1 (Marchiando
et al., 2013). However, the present observations suggest that,
contrary to previous expectations, it might be the Nod-depen-
dent signaling function rather than the autophagy-targeting
property that would be improperly modulated by the CD-associ-
ated ATG16L1 variant.
In summary, we have identified ATG16L1 as a negative regu-
lator of the Nod1 and Nod2 signaling pathway and have shown
that it functions in an autophagosome-independent manner to
negatively regulate the activation of Rip2. This regulation is
essential for modulating the response to both Nod stimulation
and infection with invasive intestinal pathogens, suggesting
that it might play a critical role at the level of the intestinal
mucosa. These results strengthen the connection between
Nod proteins and ATG16L1 and support a model in which) 2 hr after infection was assessed in control and rescued cells. Representative
ued cells (n = 7). Values shown are means + SEM. *p < 0.05, **p < 0.01 by t test.
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(legend on next page)
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cytokine responses, can contribute to dyseregulation of the
mucosal immune response.
EXPERIMENTAL PROCEDURES
Cell Culture and Transductions
Primary wild-type and Ripk2/ MEFs were prepared as previously described
(Travassos et al., 2010). Primary MEFs, wild-type MEFs, Atg5/ MEFs,
ATG16L1 DCCD immortalized MEFs, ModeK cells, MDAMCs that stably
express GFP-LC3, and HEK293T cells were grown in DMEM supplemented
with 10%FBS (Wisent). As further described in the Supplemental Experimental
Procedures, in knockdown experiments cells were seeded in 6-well plates and
transducedwith 1ml of lentivirus preparation, and 24 hr after transduction cells
were split into media containing puromycin. Knockdown cells were used
5 days after transduction. For rescue experiments, cells were transduced
with rescue lentivirus 20 hr prior to use (as described in the Supplemental
Experimental Procedures).
Infections
ModeK cells were seeded at a density of 1.2 3 105 cells/well in 24-well plates
(ELISAs) or 3 3 105 cells per well in 6-well plates (RNA) and infected the
following day. MEFs were seeded at a density of 8 3 104 cells/well in 24-
well plates. MDAMC cells were seeded at 1 3 105 cells/well in 24-well plates.
Bacteria were grown overnight as described in the Supplemental Experimental
Procedures. For infections, overnight cultures were diluted, and bacteria were
used in mid-to-late log phase at an OD650 nm of 0.5 for Shigella, 0.8 for Listeria,
and 2.3–2.6 for Salmonella. For cytokine production assays, Shigella and
Listeria were added to the cells at 50 moi (multiplicity of infection) and spun
at 2,000 rpm for 10 min. Salmonella was added to the cells at 25 MOI and
spun at 1,000 rpm for 5 min. After centrifugation, infected cells were incubated
at 37C for 20 min, cells were then washed three times with PBS, and media
containing 50 mg/ml gentamycin was added. In experiments in which bacterial
replication was blocked after invasion, medium containing 50 mg/ml of genta-
mycin and 5 mg/ml of chloroamphenicol was added. In experiments in which
autophagosomematuration was blocked, medium containing 50 mg/ml genta-
mycin and 10 mM chloroquine (Invivogen) was added 30 min after invasion.
Stimulations
ModeK or MEF cells were stimulated with 10 or 20 mg/ml C12-iE-DAP (Invivo-
Gen), 10 or 20 mg/ml L18-MDP (InvivoGen), 10 ng/mL TNF-a (InvivoGen), or
100 ng/ml LPS (InvivoGen). For inhibition of Rip2, cells were pretreated with
1 mM Rip2 inhibitor (GSK’214) for 30 min and then infected in the presence
of inhibitor for 10 hr. MDAMC cells were stimulated with 20 mg/ml C12-iE-
DAP (InvivoGen), 1 ng/ml TNF-a (InvivoGen), or 100 ng/ml LPS (InvivoGen).
ELISAs
Murine CXCL1 and human IL-8 ELISA assays were performed according to the
manufacturer’s protocols (RND Biosystems).
See Supplemental Experimental Procedures for protein blot, immunofluore-
sence, qPCR, and luciferase assay procedures.
Immunoprecipitations
For interaction experiments, HEK293T cells in 10 cm dishes were transfected
with 3 mg of HA-Nod1 or HA-Nod2 and with 500 ng of Flag-Cherry, Flag-Figure 7. The 300A Allele of ATG16L1 Is Defective in Its Regulation of
(A and B) ATG16L1-knockdown MDAMC cells were rescued with mCherry, ATG1
by qPCR examining expression of the coiled-coil domain (PCR 2) of ATG16L1 (A)
three independent experiments.
(C and D) RescuedMDAMCcells were infected with Shigella, and targeting of GFP
GFP-LC3+ Shigella 2 hr after infection was quantified (n = 3).
(E) IL-8 mRNA was measured 4.5 hr after infection with Shigella in rescued cells
shown).
(F) Percent rescue of the enhanced IL-8 response after Shigella infection of ATG
Values shown are means + SEM. *p < 0.05 by t test.
IATG16L1, Flag-85-607, or Flag-DCCD. AFter 16 hr, cells were lysed with
cold RIPA buffer. Lysates were incubated overnight at 4C with 50 ml Protein
G beads (Thermo Scientific) and 1 ml mouse anti-Flag M2 antibody (Sigma).
For Rip2 polyubiquitination assays, HEK293T cells in 10 cm dishes were trans-
fected with 50 ng of HA-Nod1 and 1.5 mg Flag-ATG16L1 or 1.5 mg pcDNA3.
After 16 hr, cells were stimulated with 1 mg/ml C12-iE-DAP and lysed in cold
RIPA buffer 30 min after stimulation. Lysates were incubated overnight at
4C with 50 ml Protein A beads (Thermo Scientific) and 1 ml rabbit anti-Rip2
antibody (Santa Cruz Biotechnology). After three washes, immunoprecipitated
proteins were analyzed by protein blot.
Sucrose-Gradient Ultracentrifugation
For sucrose-gradient experiments, HEK293T cells were transfected and
stimulated as described for Rip2 immunoprecipitations (see above). For
ModeK sucrose-gradient experiments, cells were seeded at 3 3 105 cells/
well in 6-well plates and infected with invasive or noninvasive Shigella as
described above. Three wells from a 6-well plate were pooled for each sample.
Lysates were loaded on a 3%–30% discontinuous sucrose gradient in 50 mM
Tris-HCL and 150 mM NaCL. Samples were centrifuged at 100,000 3 g for
16 hr at 4C, and fractions were collected and analyzed by protein blot.
Statistical Analysis
For Figures 1B and 2A–2C and Figures S3A, S3C, and S3G, a one-way ANOVA
followed by a Tukey post-test was used; otherwise, a Student’s t test was
used. The significance of rescue percentages was determined by comparison
of the observed rescue with a mean rescue of 0% via a one-sample t test. An
asterisk indicates p < 0.05, and two asterisks indicate p < 0.01. Unless
otherwise indicated, all experiments were performed in at least three indepen-
dent replicates.
SUPPLEMENTAL INFORMATION
Supplemental Information include Supplemental Experimental Procedures,
four figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2013.10.013.
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